+34 934 176 916info@bcnivf.com
en
  • Treatments
    • Assisted reproduction
    • Artificial insemination
    • In Vitro fertilisation
    • Egg donation
    • Embryo donation
    • Reciprocal IVF
    • Laboratory
    • ICSI and IMSI for fertilisation
    • Blastocyst culture
    • Embryoscope
    • Preimplantation genetic diagnosis
    • Sperm donor
    • Fertility preservation
    • Egg vitrification
    • Diagnosis
    • Basic sterility evaluation
    • Miscarriages and implantation failures
    • Male factor
    • Ovarian reserve
    • A type of treatment for each type of family
    • A mom
    • Mom and Dad
    • Two moms
    • Medication tutorials
    • Pricing
  • Barcelona IVF
    • Your assisted reproduction clinic
    • Why Barcelona IVF?
    • Facilities
    • Mission and vision of Barcelona IVF
    • Work with us
  • FAQs
    • Assisted reproduction
    • Infertility
    • Artificial insemination
    • Medical tests
    • In Vitro fertilisation
    • Pregnancy
    • Certifications
  • Do you want to become an egg donor?
  • Blog
  • Where we are
  • Contact us
  • Private area
  • Home
  • Blog
  • General
  • Implantation failure issues, our nearest future.

Implantation failure issues, our nearest future.

share

Embryo implantation keeps being a poorly known phenomenon because it’s very difficult to carry out in vivo tests to assess it. However nowadays is becoming more and more relevant due to the new tests available. Nevertheless we must no forget that with regards to the equation of the success, the most important factor is still the embryo quality. Therefore carrying out these new tests makes sense only when the patient has not got pregnant after three IVF attempts or two egg donation cycles provided that:

• All the transferred embryos have been of good quality
• No technical problems have been reported during the transfers
• There is no evident problem in the uterus (submucous fibroids, polyps…)

Traditionally it has been believed that implantation issues could have been due to embryo problems (either because the embryos may have genetic issues or because there are abnormalities of the pellucid zone) or uterine reasons (like chronic asymptomatic infections of the endometrium or anatomic distortions of the cavity).

Nevertheless there were other more controverted causes that, thanks to the new tests available, are getting more relevant as time goes by. They can be classified as follows:

• Patients with disorders of the endometrium receptivity due to abnormalities of the implantation window. During this “window” the endometrium, thanks to the effect of the progesterone, allows the embryo to implant. It usually lasts from 2 to 6 days. There is enough evidence that in some cases the usual protocols of progesterone are not long enough to “open this window” leading to a lack of synchronization. Because of this when the embryo tries to implant the endometrium is not ready. Nowadays this receptivity can be assessed obtaining an endometrium biopsy that allows to adequate the treatment by giving more days of progesterone whenever it’s necessary.

• Patients with thrombophilies. It has been repeatedly demonstrated a higher incidence of thrombophilies in cases of implantation failures of unknown origin. Until recently, and since the mid 90s, the only tests available were the studies of the mutations of the protrombin and the factor V of Leyden, as well as the protein S and C deficiencies. With the classic tests only 20% of the carriers were diagnosed. Nowadays there are new genetic tests performed in saliva that detect abnormalities that significantly increase the risk of thrombosis in as much as 85% of the carriers. These problems have also been related to recurrent miscarriages and/or implantation failures. By diagnosing more patients we can also treat them more efficiently using heparin. Amongst these new studies there are new mutations of the factor V (Cambridge and Hong Kong), polymorphisms of the factors XII and XIII (this one is considered especially important in the early maintenance of the pregnancy) and the presence of the blood group A1.

• Patients with immunological problems. Though it’s a controverted issue yet, there is more evidence available that suggests that in some patients the phenomenon known as “immunological tolerance” (which allows the mother to carry the baby during the 9 months of pregnancy without considering it a “foreign body” that should be attacked) does not take place as it should. Though various groups carry out tests in blood studying different factors that may alter the implantation or the early development of the embryo, it seems that the cells that can be studied in blood do not belong to the same family of those present at the endometrium (the ones that indeed take part in the implantation process). Because of this BarcelonaIVF carries out the immunological studies performing an endometrium biopsy with the intention to know what really happens where the implantation takes place. When this test shows abnormal figures using steroids to cause immunosuppression is a good option.
 

share
0 Comments
Leave a Reply
We receive many queries and it is not possible for us to provide a personal response to all comments. We will try to answer as soon as possible. In the meantime, we invite you to check our FAQ in case they can help you.
* This is a required field
Categories
  • All categories
  • Assisted reproduction
  • Barcelona IVF
  • General
  • Health and fertility
Most read
  • How to calculate the date of delivery after an IVF?
  • Genetic testing and assisted reproduction
  • Symptoms of embryo implantation
  • Blocked Fallopian Tubes, Is there any solution?
  • Infertility treatments: what to expect or not to expect in the 2 ww.
  • Changes in vaginal discharge
  • Hygiene after delivery
  • Lateral or inclined uterus: how does it affect fertility?
  • What are KIR receptors and what use do they have in clinical practice?
  • Travelling while pregnant. What should I consider?
Shall we call you?
Book a consultation
Barcelona IVF

Planetarium Building
Escoles Pies, 103. 08017 Barcelona, Spain

+34 934 176 916 | info@bcnivf.com

Barcelona IVF is a Healthcare Centre approved by the Generalitat of Catalonia and authorized to operate as a Human Assisted Reproduction Centre with code no. E08050604

  • Premio a la calidad Sistema Nacional de Salud 2022-2023
  • TUVRHeinland ISO 9001:2015
  • TUVRHeinland UNE 179007:2013
  • WIS - Web d’interés sanitari
  • Ministeri de sanitat serveis socials i igualtat
  • UAB - Universitat Autònoma de Barcelona
Work with us
  • Legal notice
  • Cookies policy
  • Privacy policy